XML 79 R60.htm IDEA: XBRL DOCUMENT v3.4.0.3
RESTATEMENT - Cash Flows (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Jun. 30, 2015
Jun. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Net Cash Provided by (Used in) Operating Activities [Abstract]                              
Net (loss) income                         $ (287.8) $ 879.4 $ (863.6)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:                              
Depreciation and amortization, including impairments of finite-lived intangible assets                         2,627.5 1,737.6 2,015.8
Amortization and write-off of debt discounts and debt issuance costs                         145.3 70.0 89.5
In-process research and development impairments                         144.5 21.0 151.9
Acquisition accounting adjustment on inventory sold                         133.7 27.3 372.4
Acquisition-related contingent consideration                         (23.0) (14.1) (29.2)
Allowances for losses on accounts receivable and inventories                         115.3 81.3 68.3
Deferred income taxes                         (7.0) 75.6 (515.9)
Loss (gain) on disposal of assets and businesses                         5.4 (253.5) 10.2
Additions (reduction) to accrued legal settlements                         37.3 (44.7) 220.5
Payments of accrued legal settlements                         (32.9) (3.2) (180.8)
Share-based compensation                         140.1 78.2 45.5
Tax benefits from share-based compensation                         (56.8) (17.1) (24.2)
Foreign exchange loss                         95.2 135.1 9.8
Loss on extinguishment of debt               $ 94.0         20.0 129.6 65.0
Payment of accreted interest on contingent consideration                         (23.0) (10.7) (11.1)
Other                         (11.2) 32.3 (3.8)
Changes in operating assets and liabilities:                              
Trade receivables                         (625.9) (572.4) (300.6)
Inventories                         (276.0) (192.8) (122.7)
Prepaid expenses and other current assets                         (90.6) (110.3) 121.5
Accounts payable, accrued and other liabilities                         170.3 246.1 (76.5)
Net cash provided by operating activities $ 562.3 $ 736.5 $ 410.5 $ 491.1 $ 815.7 $ 618.7 $ 376.0 484.3 $ 901.6 $ 860.3 $ 1,638.1 $ 1,479.0 2,200.4 2,294.7 1,042.0
Net cash used in investing activities                         (15,577.4) (99.7) (5,380.3)
Net cash provided by financing activities                         13,681.8 (2,443.7) 4,027.7
Effect of exchange rate changes on cash and cash equivalents                         (30.1) (29.0) (5.2)
Net increase (decrease) in cash and cash equivalents                         274.7 (277.7) (315.8)
Cash and cash equivalents, beginning of year       322.6       600.3 322.6 600.3 322.6 600.3 322.6 600.3 916.1
Cash and cash equivalents, end of year 597.3       322.6               597.3 322.6 600.3
Noncash Investing and Financing Items [Abstract]                              
Acquisition of businesses, contingent and deferred consideration obligations at fair value                         (1,695.8) (132.6) (76.1)
Acquisition of businesses, debt assumed                         (3,129.2) (11.2) (4,264.7)
Revenue recognition correction                              
Net Cash Provided by (Used in) Operating Activities [Abstract]                              
Net (loss) income       98.5 511.7 266.0     46.9   98.6 367.7   879.4  
Adjustments to reconcile net (loss) income to net cash provided by operating activities:                              
Depreciation and amortization, including impairments of finite-lived intangible assets       407.0   439.3     1,042.0   1,768.4 1,248.1   1,737.6  
Amortization and write-off of debt discounts and debt issuance costs       10.5   34.6     103.2   123.7 58.1   70.0  
In-process research and development impairments           19.9     12.3   108.1 20.3   21.0  
Acquisition accounting adjustment on inventory sold       24.5   12.4     70.5   97.7 21.9   27.3  
Acquisition-related contingent consideration       7.1   4.0     18.8   22.6 14.8   (14.1)  
Allowances for losses on accounts receivable and inventories       12.2   12.0     26.8   46.4 47.6   81.3  
Deferred income taxes       66.1   72.7     16.0   (75.4) 61.3   75.6  
Loss (gain) on disposal of assets and businesses           (254.5)         9.2 (254.5)   (253.5)  
Additions (reduction) to accrued legal settlements       1.5   (0.9)     6.3   31.9 (48.2)   (44.7)  
Payments of accrued legal settlements       (3.0)   (0.2)     (5.9)   (32.1) (1.2)   (3.2)  
Share-based compensation       35.0   20.2     60.9   111.4 60.6   78.2  
Tax benefits from share-based compensation       (17.9)   (15.9)     (25.6)   (21.7) (17.1)   (17.1)  
Foreign exchange loss       75.9   55.1     65.6   96.6 62.4   135.1  
Loss on extinguishment of debt       20.0 35.9 0.0     20.0   20.0 93.7   129.6  
Payment of accreted interest on contingent consideration       (2.2)   (1.3)     (12.1)   (19.8) (9.5)   (10.7)  
Other       (7.2)   9.7     (9.9)   (13.6) 15.8   32.3  
Changes in operating assets and liabilities:                              
Trade receivables       (67.0)   (121.4)     (308.8)   (656.0) (205.2)   (572.4)  
Inventories       (91.0)   (42.1)     (139.3)   (184.9) (123.4)   (192.8)  
Prepaid expenses and other current assets       (45.1)   5.5     (163.5)   (252.0) 34.5   (110.3)  
Accounts payable, accrued and other liabilities       (33.8)   103.6     77.4   359.0 31.3   246.1  
Net cash provided by operating activities       491.1   618.7     901.6   1,638.1 1,479.0   2,294.7  
Net cash used in investing activities       (11,240.5)   756.3     (13,885.7)   (14,041.9) 105.8   (99.7)  
Net cash provided by financing activities       12,306.3   (1,082.1)     13,631.6   13,523.2 (1,361.4)   (2,443.7)  
Effect of exchange rate changes on cash and cash equivalents       (15.1)   (15.3)     (12.1)   (22.0) (14.9)   (29.0)  
Net increase (decrease) in cash and cash equivalents       1,541.8   277.6     635.4   1,097.4 208.5   (277.7)  
Cash and cash equivalents, beginning of year 1,420.0 958.0 1,864.4 322.6 808.8 531.2   600.3 322.6 600.3 322.6 600.3 322.6 600.3  
Cash and cash equivalents, end of year   1,420.0 958.0 1,864.4 322.6 808.8 531.2   958.0 531.2 1,420.0 808.8   322.6 600.3
Noncash Investing and Financing Items [Abstract]                              
Acquisition of businesses, contingent and deferred consideration obligations at fair value       (286.9)   (16.0)     (635.8)   (744.5) (65.1)   (132.6)  
Acquisition of businesses, debt assumed       0.0   (4.5)     (3,123.1)   (3,129.2) (8.5)   (11.2)  
Revenue recognition correction | Previously reported                              
Net Cash Provided by (Used in) Operating Activities [Abstract]                              
Net (loss) income       74.5 534.1 276.4     22.9   74.6 378.1   912.2  
Adjustments to reconcile net (loss) income to net cash provided by operating activities:                              
Depreciation and amortization, including impairments of finite-lived intangible assets       407.0   439.3     1,042.0   1,768.4 1,248.1   1,737.6  
Amortization and write-off of debt discounts and debt issuance costs       10.5   34.6     103.2   123.7 58.1   70.0  
In-process research and development impairments           19.9     12.3   108.1 20.3   21.0  
Acquisition accounting adjustment on inventory sold       24.5   12.4     70.5   97.7 21.9   27.3  
Acquisition-related contingent consideration       7.1   4.0     18.8   22.6 14.8   (14.1)  
Allowances for losses on accounts receivable and inventories       12.2   12.0     26.8   46.4 47.6   81.3  
Deferred income taxes       62.5   74.6     12.4   (79.0) 63.2   81.8  
Loss (gain) on disposal of assets and businesses           (254.5)         9.2 (254.5)   (253.5)  
Additions (reduction) to accrued legal settlements       1.5   (0.9)     6.3   31.9 (48.2)   (44.7)  
Payments of accrued legal settlements       (3.0)   (0.2)     (5.9)   (32.1) (1.2)   (3.2)  
Share-based compensation       35.0   20.2     60.9   111.4 60.6   78.2  
Tax benefits from share-based compensation       (17.9)   (15.9)     (25.6)   (21.7) (17.1)   (17.1)  
Foreign exchange loss       75.9   55.1     65.6   96.6 62.4   135.1  
Loss on extinguishment of debt       20.0 35.9 0.0     20.0   20.0 93.7   129.6  
Payment of accreted interest on contingent consideration       (2.2)   (1.3)     (12.1)   (19.8) (9.5)   (10.7)  
Other       (7.2)   9.7     (9.9)   (13.6) 15.8   32.3  
Changes in operating assets and liabilities:                              
Trade receivables       (67.0)   (121.4)     (308.8)   (656.0) (205.2)   (572.4)  
Inventories       (38.5)   (41.5)     (86.8)   (132.4) (122.8)   (174.3)  
Prepaid expenses and other current assets       (45.1)   5.5     (163.5)   (252.0) 34.5   (110.3)  
Accounts payable, accrued and other liabilities       (58.7)   90.7     52.5   334.1 18.4   188.6  
Net cash provided by operating activities       491.1   618.7     901.6   1,638.1 1,479.0   2,294.7  
Net cash used in investing activities       (11,240.5)   756.3     (13,885.7)   (14,041.9) 105.8   (99.7)  
Net cash provided by financing activities       12,306.3   (1,082.1)     13,631.6   13,523.2 (1,361.4)   (2,443.7)  
Effect of exchange rate changes on cash and cash equivalents       (15.1)   (15.3)     (12.1)   (22.0) (14.9)   (29.0)  
Net increase (decrease) in cash and cash equivalents       1,541.8   277.6     635.4   1,097.4 208.5   (277.7)  
Cash and cash equivalents, beginning of year 1,420.0 958.0 1,864.4 322.6 808.8 531.2   600.3 322.6 600.3 322.6 600.3 322.6 600.3  
Cash and cash equivalents, end of year   1,420.0 958.0 1,864.4 322.6 808.8 531.2   958.0 531.2 1,420.0 808.8   322.6 600.3
Noncash Investing and Financing Items [Abstract]                              
Acquisition of businesses, contingent and deferred consideration obligations at fair value       (286.9)   (16.0)     (674.6)   (783.3) (65.1)   (93.8)  
Acquisition of businesses, debt assumed       0.0   (4.5)     (3,123.1)   (3,129.2) (8.5)   (11.2)  
Revenue recognition correction | Restatement adjustments                              
Net Cash Provided by (Used in) Operating Activities [Abstract]                              
Net (loss) income       24.0 (22.4) (10.4)     24.0   24.0 (10.4)   (32.8)  
Adjustments to reconcile net (loss) income to net cash provided by operating activities:                              
Depreciation and amortization, including impairments of finite-lived intangible assets       0.0   0.0     0.0   0.0 0.0   0.0  
Amortization and write-off of debt discounts and debt issuance costs       0.0   0.0     0.0   0.0 0.0   0.0  
In-process research and development impairments           0.0     0.0   0.0 0.0   0.0  
Acquisition accounting adjustment on inventory sold       0.0   0.0     0.0   0.0 0.0   0.0  
Acquisition-related contingent consideration       0.0   0.0     0.0   0.0 0.0   0.0  
Allowances for losses on accounts receivable and inventories       0.0   0.0     0.0   0.0 0.0   0.0  
Deferred income taxes       3.6   (1.9)     3.6   3.6 (1.9)   (6.2)  
Loss (gain) on disposal of assets and businesses           0.0         0.0 0.0   0.0  
Additions (reduction) to accrued legal settlements       0.0   0.0           0.0      
Payments of accrued legal settlements       0.0   0.0     0.0   0.0 0.0   0.0  
Share-based compensation       0.0   0.0     0.0   0.0 0.0   0.0  
Tax benefits from share-based compensation       0.0   0.0     0.0   0.0 0.0   0.0  
Foreign exchange loss       0.0   0.0     0.0   0.0 0.0   0.0  
Loss on extinguishment of debt       0.0 0.0 0.0     0.0   0.0 0.0   0.0  
Payment of accreted interest on contingent consideration       0.0   0.0     0.0   0.0 0.0   0.0  
Other       0.0   0.0     0.0   0.0 0.0   0.0  
Changes in operating assets and liabilities:                              
Trade receivables       0.0   0.0     0.0   0.0 0.0   0.0  
Inventories       (52.5)   (0.6)     (52.5)   (52.5) (0.6)   (18.5)  
Prepaid expenses and other current assets       0.0   0.0     0.0   0.0 0.0   0.0  
Accounts payable, accrued and other liabilities       24.9   12.9     24.9   24.9 12.9   57.5  
Net cash provided by operating activities       0.0   0.0     0.0   0.0 0.0   0.0  
Net cash used in investing activities       0.0   0.0     0.0   0.0 0.0   0.0  
Net cash provided by financing activities       0.0   0.0     0.0   0.0 0.0   0.0  
Effect of exchange rate changes on cash and cash equivalents       0.0   0.0     0.0   0.0 0.0   0.0  
Net increase (decrease) in cash and cash equivalents       0.0   0.0     0.0   0.0 0.0   0.0  
Cash and cash equivalents, beginning of year $ 0.0 0.0 0.0 0.0 0.0 0.0   $ 0.0 0.0 0.0 0.0 0.0 $ 0.0 0.0  
Cash and cash equivalents, end of year   $ 0.0 $ 0.0 0.0 $ 0.0 0.0 $ 0.0   0.0 $ 0.0 0.0 0.0   0.0 $ 0.0
Noncash Investing and Financing Items [Abstract]                              
Acquisition of businesses, contingent and deferred consideration obligations at fair value       0.0   0.0     38.8   38.8 0.0   (38.8)  
Acquisition of businesses, debt assumed       $ 0.0   $ 0.0     $ 0.0   $ 0.0 $ 0.0   $ 0.0